Therapeutic Strategies to Activate p53 is a research paper published in Pharmaceuticals (2022). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH HHS
Grant: R01CA219345
National Institutes of Health
Grant: 5R01CA219345-04
Small-molecule MDM2 degraders
National Cancer Institute
Ascentage Pharma Group
FWCI
2.14
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals